首页 | 本学科首页   官方微博 | 高级检索  
     

基于TCGA 数据库分析DTX2 在肾透明细胞癌组织中表达的临床意义及其对肾癌细胞增殖、迁移与侵袭的影响
引用本文:秦翰成,刘婉璐,静雅杰,陈志鸿. 基于TCGA 数据库分析DTX2 在肾透明细胞癌组织中表达的临床意义及其对肾癌细胞增殖、迁移与侵袭的影响[J]. 中国肿瘤生物治疗杂志, 2024, 31(4): 383-391
作者姓名:秦翰成  刘婉璐  静雅杰  陈志鸿
作者单位:1. 右江民族医学院 基础医学院,广西 百色 533000;2. 宿州学院 生物与食品工程学院,安徽 宿州 234000
基金项目:国家自然科学基金(No. 82160502);宿州学院博士科研启动基金(No. 2023BSK021)
摘    要:目的:基于TCGA数据库分析Deltex E3泛素连接酶2(DTX2)在肾透明细胞癌(ccRCC)组织中的表达水平及临床意义,探讨DTX2对ccRCC细胞增殖、迁移和侵袭的影响。方法:利用TIMER数据库分析DTX2在泛癌组织中的表达水平,通过UALCAN数据库进一步验证ccRCC组织和癌旁组织中DTX2 mRNA和蛋白表达差异。使用UALCAN数据库中的TCGAccRCC队列数据集,分析ccRCC中DTX2表达与患者临床病理特征的相关性。通过K-M plot数据库分析DTX2表达与cc RCC患者预后的相关性。利用DAVID数据库对DTX2相关基因进行GO和KEGG通路富集分析。通过qPCR法检测DTX2基因在人胚肾293(HEK293)细胞和ccRCC细胞A498、Caki-1中的表达水平。利用siRNA技术分别将DTX2 siRNA及其阴性对照质粒转入A498、Caki-1细胞,采用CCK-8法、平板克隆实验、划痕实验及Transwell侵袭实验分别检测敲低DTX2对细胞增殖、迁移和侵袭的影响。结果:TCGA数据库分析结果表明,与癌旁组织相比,ccRCC组织中DTX2 mRNA和...

关 键 词:Deltex E3泛素连接酶2  肾透明细胞癌  增殖  迁移  侵袭  临床意义
收稿时间:2023-11-08
修稿时间:2024-03-17

Clinical significance of DTX2 expression in clear cell renal cell carcinoma tissues and its effect on renal cancer cell proliferation, migration and invasion based on TCGA database
QIN Hancheng,LIU Wanlu,JING Yajie,CHEN Zhihong. Clinical significance of DTX2 expression in clear cell renal cell carcinoma tissues and its effect on renal cancer cell proliferation, migration and invasion based on TCGA database[J]. Chinses Journal of Cancer Biotherapy, 2024, 31(4): 383-391
Authors:QIN Hancheng  LIU Wanlu  JING Yajie  CHEN Zhihong
Affiliation:1. School of Basic Medicine, Youjiang Medical University for Nationalities, Baise 533000, Guangxi, China; 2. School of Biological and Food Engineering, Suzhou University, Suzhou 234000, Anhui, China
Abstract:Objective:To analyze the expression level and clinical significance of Deltex E3 ubiquitin ligase 2 (DTX2) in clear cell renal cell carcinoma (ccRCC) based on TCGA database, and explore the effect of DTX2 on the proliferation, migration and invasion of ccRCC cells. Methods: TIMER database was utilized to analyze the expression level of DTX2 in pan-cancer tissues, while UALCAN database was used for further verification of the differences in mRNA and protein expressions of DTX2 in ccRCC and adjacent tissues. TCGA-ccRCC cohort dataset in UALCAN database was employed to examine the correlation between DTX2 expression in ccRCC and clinicopathological features of patients. The correlation between DTX2 expression and the prognosis of ccRCC patients was analyzed using K-M plot database. Using DAVID database, gene ontology (GO) analysis and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed to explore DTX2-related genes. The expression levels of DTX2 gene in human embryonic kidney 293 (HEK293) cells and ccRCC A498 and Caki-1 cells were detected by qPCR. SiRNA technology was employed to transfect DTX2 siRNA and its negative control plasmids into ccRCC A498 and Caki-1 cells. CCK-8 cell proliferation assay, plate clone formation assay, scratch wound assay, and Transwell migration assay were performed to detect respectively the effects of knockdown DTX2 on the proliferation, migration and invasion of ccRCC cells. Results: Analysis of TCGA database showed that, compared with adjacent tissues, both DTX2 mRNA and protein were highly expressed in ccRCC tissues (all P<0.01). The expression level of DTX2 was associated with the pathological stage, clinical grade, different subtype, and lymph node metastasis of ccRCC patients (all P<0.01). High DTX2 expression was correlated with poor prognosis in patients (all P<0.01). The results of GO function analysis and KEGG pathway enrichment analysis and showed that genes related to DTX2 expression were mainly involved in biological processes such as proteasome-mediated ubiquitin-dependent protein catabolic process, and these genes were primarily enriched in tumor-related signaling pathways such as the mTOR signaling pathway (all P<0.05).The results of in vitro cell experiments showed that the expression levels of DTX2 in A498 and Caki-1 cells were higher than those in HEK293 cells; knockdown of DTX2 expression significantly lowered the proliferation, migration and invasion abilities of A498 and Caki-1 cells (all P<0.01). Conclusion: High expression of DTX2 is observed in ccRCC tissues and cells, and its high expression is associated with poor prognosis in patients. Knockdown of DTX2 expression may inhibit the proliferation, migration and invasion of ccRCC cells. DTX2 is expected to become a new biomarker and therapeutic target for ccRCC.
Keywords:Deltex E3 ubiquitin ligase 2 (DTX2)   clear cell renal cell carcinoma (ccRCC)   proliferation   migration   invasion  clinical significance
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号